Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Krishna Institute of Medical Sciences Limited ( (IN:KIMS) ) just unveiled an update.
Krishna Institute of Medical Sciences Limited has submitted a compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31 March 2026, as confirmed by its registrar and share transfer agent MUFG Intime India Private Limited. The registrar has verified that all securities received for dematerialisation during the quarter were properly processed, listed on the relevant stock exchanges, and that corresponding physical certificates were cancelled and records updated within prescribed timelines, underscoring the company’s adherence to regulatory norms in handling its share capital.
This confirmation supports transparency and integrity in KIMS’s shareholding records, which is important for investors relying on accurate dematerialised holdings. By maintaining timely and compliant demat procedures, the company reinforces its corporate governance standards and reduces operational and settlement risks for market participants.
More about Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited (KIMS) operates in the healthcare sector, running multi-specialty hospitals and related medical services in India. Its shares are listed on the Bombay Stock Exchange and the National Stock Exchange under the symbol KIMS, with its equity represented in dematerialised form through recognised depositories.
Average Trading Volume: 46,678
Technical Sentiment Signal: Strong Buy
Current Market Cap: 265.5B INR
For a thorough assessment of KIMS stock, go to TipRanks’ Stock Analysis page.